Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

BackgroundCoronavirus disease 2019 (COVID‐19) is a highly contagious respiratory disease that has posed a serious threat to people’s daily lives and caused an unprecedented challenge to public health and people’s health worldwide. Lung squamous cell carcinoma (LUSC) is a common type of lung malignan...

Full description

Bibliographic Details
Main Authors: Wen-yu Wu, Xin Jiao, Wen-xin Song, Peng Wu, Pei-qi Xiao, Xiu-fang Huang, Kai Wang, Shao-feng Zhan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Endocrinology
Subjects:
COVID-19
lung squamous cell carcinoma
naringenin
network pharmacology
bioinformatics
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1187882/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1187882/full

Similar Items